Clinical efficacy and safety of cefluprenam (CFLP) were evaluated in 11 patients with respiratory infections. CFLP were administered intravenously 0.5g or 1.0g twice daily. The duration of treatment ranged from 4 to 17 days. Clinical efficacy was excellent in 4, good in 6 and poor in one patient. Skin rash was observed in 1 patient, and abnormal laboratory findings were observed in 2 patients. The results suggest that CFLP is useful for treatment of respiratory infections.
|Number of pages||4|
|Journal||Japanese Journal of Chemotherapy|
|Publication status||Published - 01-01-1995|
All Science Journal Classification (ASJC) codes
- Pharmacology (medical)